Assessment of liver function

Hilar Cholangiocarcinoma

Volumn , Issue , 2013, Pages 75-89

  Mann, D V ^a  

^a NONE   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84929466209     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-94-007-6473-6_7     Document Type: Chapter

References (65)

1. Yamanaka N, Okamoto E, Kawamura E, et al. Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function. Hepatology. 1993;18:79-85.
2. Yokoyama Y, Nagino M, Nimura Y. Mechanism of impaired hepatic regeneration in cholestatic liver. J Hepatobiliary Pancreat Surg. 2007;14:159-66.
3. Schroeder R, Marroquin C, Bute B, et al. Predictive indices of morbidity and mortality after liver resection. Ann Surg. 2006;243:373-9.
4. Sitzmann J, Greene P. Perioperative predictors of morbidity following hepatic resection for neoplasm. Ann Surg. 1994;219:13-7.
5. Noun R, Jagot P, Farges O, et al. High preoperative serum alanine transferase levels: effect on the risk of liver resection in child grade A cirrhotic patients. World J Surg. 1997;21:390-5.
6. Didolkar M, Fitzpatrick L, Elias G, et al. Risk factors before hepatectomy, hepatic function after hepatectomy and computed tomographic changes as indicators of mortality from hepatic failure. Surg Gynecol Obstet. 1989;169:17-26.
7. Pugh R, Murray-Lyon I, Dawson J, et al. Transection of the oesophagus for bleeding oesphageal varices. Br J Surg. 1973;60:646-9.
8. Franco D, Capussotti L, Smadja C, et al. Resection of hepatocellular carcinomas. Gastroenterology. 1990;98:733-8.
9. Nonami T, Harada A, Kurokawa T, et al. Hepatic resection for hepatocellular carcinoma. Am J Surg. 1997;173:288-91.
10. Vauthey J, Klimstra D, Franceschi D, et al. Factors affecting longterm outcome after hepatic resection for hepatocellular carcinoma. Am J Surg. 1995;169:28-35.
11. Freeman R, Wiesner R, Roberts J, et al. Improving liver allocation: MELD and PELD. Am J Transplant. 2004;4:114-31.
12. Cucchetti A, Ercolani G, Vivarelli M, et al. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl. 2006;12:966-71.
13. Okamoto E, Kyo A, Yamanaka N, et al. Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. Surgery. 1984; 95:586-92.
14. Soyer P, Roche A, Elias D, et al. Hepatic metastases from colorectal cancer: in fluence of hepatic volumetric analysis on surgical decision making. Radiology. 1992;184:695-7.
15. Belghiti J, Ogata S. Assessment of hepatic reserve for the indication of hepatic resection. J Hepatobiliary Pancreat Surg. 2005; 12:1-3.
16. Yamanaka N, Okamoto E, Oriyama T, et al. A prediction scoring system to select the surgical treatment of liver cancer. Ann Surg. 1994;219:342-6.
17. Behrns K, Tsiotos G, Desouza N, et al. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg. 1998;2:292-8.
18. Atkinson D. The energy charge of the adenylate pool as a regulatory parameter: interaction with feedback modi fiers. Biochemistry. 1968;7:4030-4.
19. Williamson D, Lund P, Krebs H. The redox state of free nicotinamide- adenine dinucleotides in the cytoplasma and mitochondria of rat liver. Biochem J. 1967;103:514-27.
20. Ozawa K, Fujimoto T, Nakatani T, et al. Changes in hepatic energy charge, blood ketone body ratio, and indocyanine green clearance in relation to DNA synthesis after hepatectomy. Life Sci. 1982; 31:647-53.
21. Mori K, Ozawa K, Yamamoto Y, et al. Response of hepatic mitochondrial redox state to oral glucose load: redox tolerance test as a new predictor of surgical risk in hepatectomy. Ann Surg. 1990;211: 438-46.
22. Kiuchi T, Ozawa K, Yamamoto Y, et al. Changes in arterial ketone body ratio in the phase immediately after hepatectomy: prognostic implications. Arch Surg. 1990;125:655-9.
23. Komura M, Chijiwa K, Naito T, et al. Sequential changes of energy charge, lipoperoxide level, and DNA synthesis rate of the liver following biliary obstruction in rats. J Surg Res. 1996;61:503-8.
24. Jikko A, Taki Y, Nakamura N, et al. Adenylate energy charge and cytochrome a(+a3) in the cirrhotic rat liver. J Surg Res. 1984;37: 361-8.
25. Sakai Y, Tanaka A, Ikai I, et al. Cytochrome c oxidase activity in human liver specimens: an index of prognosis for hepatic resection. Arch Surg. 1990;125:632-5.
26. Gadian D. Nuclear magnetic resonance and its applications to living systems. Oxford: Clarendon; 1982.
27. Menon D, Sargentoni J, Taylor-Robinson S, et al. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Hepatology. 1995;21:417-27.
28. Mann D, Lam W, Hjelm N, et al. Metabolic control patterns in acute phase and regenerating human liver determined in vivo by 31- phosphorus magnetic resonance spectroscopy. Ann Surg. 2002; 235:408-16.
29. Mann D, Lam W, Hjelm N, et al. Biliary drainage for obstructive jaundice enhances hepatic energy status in humans: a 31-phosphorus magnetic resonance spectroscopy study. Gut. 2002;50:118-22.
30. Maris J, Evans A, McLaughlin A, et al. 31P nuclear magnetic resonance spectroscopic investigation of human neuroblastoma in situ. N Engl J Med. 1985;312:1500-5.
31. van Wassenaer-van Hall H, van der Grond J, van Hattum J, et al. 31P magnetic resonance spectroscopy of the liver: correlation with standardized serum, clinical, and histological changes in diffuse liver disease. Hepatology. 1995;21:443-9.
32. Jalan R, Sargentoni J, Coutts G, et al. Hepatic phosphorus-31 magnetic resonance spectroscopy in primary biliary cirrhosis and its relation to prognostic models. Gut. 1996;39:141-6.
33. Hemming A, Scudamore C, Shackleton C, et al. Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg. 1992;163:515-8.
34. Fan S, Lai C, Lo C, et al. Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg. 1995;130:198-203.
35. Lau H, Man K, Fan S, et al. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg. 1997;84:1255-9.
36. Kawasaki S, Makuuchi M, Miyagawa S, et al. Results of hepatic resection for hepatocellular carcinoma. World J Surg. 1995;19:31-4.
37. Yokoyama Y, Nishio H, Ebata T, et al. Value of indocyanine green clearance of the future liver remnant in predicting outcome after resection for biliary cancer. Br J Surg. 2010;97:1260-8.
38. Matsumata T, Kanematsu T, Yoshida Y, et al. The indocyanine green test enables prediction of postoperative complications after hepatic resection. World J Surg. 1987;11:678-81.
39. Stockmann M, Malinowski M, Lock J, et al. Factors in fluencing the indocyanine green (ICG) test: additional impact of acute cholestasis. Hepatogastroenterology. 2009;56:734-8.
40. Chijiiwa K, Watanabe M, Nakano K, et al. Biliary indocyanine green excretion as a predictor of hepatic adenosine triphosphate levels in patients with obstructive jaundice. Am J Surg. 2000;179: 161-6.
41. Jiao L, El-Desoky A, Seifalian A, et al. Effect of liver blood flow and function on hepatic indocyanine green clearance measured directly in a cirrhotic animal model. Br J Surg. 2000;87:568-74.
42. Gill R, Goodman M, Golfus G, et al. Aminopyrine breath test predicts surgical risk for patients with liver disease. Ann Surg. 1983;198:701-4.
43. Cohnert T, Rau H, Buttler E, et al. Preoperative risk assessment of hepatic resection for malignant disease. World J Surg. 1997;21: 396-401.
44. Ercolani G, Grazi G, Calliva R, et al. The lidocaine (MEGX) test as an index of hepatic function: its clinical usefulness in liver surgery. Surgery. 2000;127:464-71.
45. Redaelli C, Dufour J, Wagner M, et al. Preoperative galactose elimination capacity predicts complications and survival after hepatic resection. Ann Surg. 2002;235:77-85.
46. Sakuma H, Itabashi K, Takeda K, et al. Serial P-31 MR spectroscopy after fructose infusion in patients with chronic hepatitis. J Magn Reson Imaging. 1991;1:701-4.
47. Bennink R, Dinant S, Erdogan D, et al. Preoperative assessment of postoperative remnant liver function using hepatobiliary scintigraphy. J Nucl Med. 2004;45:965-71.
48. Kwon A-H, Ha-Kawa S, Uetsuji S, et al. Preoperative determination of the surgical procedure for hepatectomy using technetium- 99m-galactosyl human serum albumin (99mTc-GSA) liver scintigraphy. Hepatology. 1997;25:426-9.
49. Satoh K, Yamamoto Y, Nishiyama Y, et al. 99mTc-GSA liver dynamic SPECT for the preoperative assessment of hepatectomy. Ann Nucl Med. 2003;17:61-7.
50. Kwon A-H, Matsui Y, Kaibori M, et al. Preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin (GSA-Rmax) is useful for judging the safety of hepatic resection. Surgery. 2006;140:379-86.
51. Abdalla E, Hicks M, Vauthey J. Portal vein embolization: rationale, technique and future prospects. Br J Surg. 2001;88:165-75.
52. Uesaka K, Nimura Y, Nagino M. Changes in hepatic lobar function after right portal vein embolization: an appraisal by biliary indocyanine green excretion. Ann Surg. 1996;223:77-83.
53. Chijiiwa K, Saiki S, Noshiro H, et al. Effect of preoperative portal vein embolization on liver volume and hepatic energy status of the nonembolized liver lobe in humans. Eur Surg Res. 2000; 32:94-9.
54. Kubo S, Shiomi S, Tanaka H, et al. Evaluation of the effect of portal vein embolization on liver function by 99mTc-galactosyl human serum albumin scintigraphy. J Surg Res. 2002;107:113-8.
55. Balzan S, Belghiti J, Farges O, et al. The "50-50 Criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005;242:824-9.
56. Cucchetti A, Ercolani G, Cescon M, et al. Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease. J Am Coll Surg. 2006;203:670-6.
57. Francavilla A, Panella C, Polimeno L, et al. Hormonal and enzymatic parameters of hepatic regeneration in patients undergoing major liver resections. Hepatology. 1990;12:1134-8.
58. Ove P, Takai S, Umeda T, et al. Adenosine triphosphate in liver after partial hepatectomy and acute stress. J Biol Chem. 1967; 242:4963-71.
59. Kamiyama Y, Ozawa K, Honjo I. Changes in mitochondrial phosphorylative activity and adenylate energy charge of regenerating rabbit liver. J Biochem. 1976;80:875-81.
60. Rikkers L, Moody F. Estimation of functional hepatic mass in resected and regenerating rat liver. Gastroenterology. 1974;67: 691-9.
61. Okochi O, Kaneko T, Sugimoto H, et al. ICG pulse spectrophotometry for perioperative liver function in hepatectomy. J Surg Res. 2002;103:109-13.
62. Ozawa K. Liver surgery approached through the mitochondria. Tokyo: Medical Tribune; 1992.
63. Sugimoto H, Okochi O, Hirota M, et al. Early detection of liver failure after hepatectomy by indocyanine green elimination rate measured by pulse dye-densitometry. J Hepatobiliary Pancreat Surg. 2006;13:543-8.
64. Mann D, Lam W, Hjelm N, et al. Human liver regeneration: hepatic energy economy is less ef ficient when the organ is diseased. Hepatology. 2001;34:557-65.
65. Demetriou A, Brown R, Busuttil R, et al. Prospective, randomized, multicenter, controlled trial of a bioarti ficial liver in treating acute liver failure. Ann Surg. 2004;239:660-70.